Vaccination against Yersiniosis

Bridle, Andrew R.; Nowak, Barbara

doi:10.1002/9781118806913.ch19

Cited by 2 publications

(2 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The first fish vaccine was used against enteric-redmouth in fish, for treating yersiniosis in the year 1976 and was licensed by the United States (US) Department of Agriculture, followed by a vaccine for vibriosis (Gudding and Muiswinkel 2013 ; Bridle and Nowak 2014 ; Kumar et al 2015 ). The vaccines for bacterial infections, yersiniosis, and vibriosis are even now the most highly effective commercial vaccines available in the market.…”

Section: Introductionmentioning

confidence: 99%

A review on the recent advances and application of vaccines against fish pathogens in aquaculture

Mondal

Thomas

2022

Aquacult Int

View full text Add to dashboard Cite

Globally, aquaculture has faced serious economic problems due to bacterial, viral, and various other infectious diseases of different origins. Even though such diseases are being detected and simultaneously treated with several therapeutic and prophylactic methods, the broad-spectrum activity of vaccines plays a vital role as a preventive measure in aquaculture. However, treatments like use of antibiotics and probiotics seem to be less effective when new mutant strains develop and disease causing pathogens become resistant to commonly used antibiotics. Therefore, vaccines developed by using recent advanced molecular techniques can be considered as an effective way of treating disease causing pathogens in aquatic organisms. The present review emphasizes on the current advances in technology and future outlook with reference to different types of vaccines used in the aquaculture industries. Beginning with traditional killed/inactivated and live attenuated vaccines, this work culminates in the review of modern new generation ones including recombinant, synthetic peptides, mucosal and DNA, subunit, nanoparticle-based and plant-based edible vaccines, reverse vaccinology, and monovalent and polyvalent vaccines.

show abstract

Section: Introductionmentioning

confidence: 99%

A review on the recent advances and application of vaccines against fish pathogens in aquaculture

Mondal

Thomas

2022

Aquacult Int

View full text Add to dashboard Cite

show abstract

“…A similar study based on prescription data for the period 1991 to 2000 concluded that the reduction in sales from 27.5 tons of active substance in 1992 to 6.1 t in 1993, and further to 1.4 tons in 1994, was due to the implementation of full-scale vaccination programmes with efficient vaccines against vibriosis, cold-water vibriosis and furunculosis in salmonids from 1993 (Lillehaug et al 2003). Since then, the vaccination programme has been followed, and vaccines have also been introduced against the bacterial infections winter ulcers caused by Moritella viscosa (Colquhoun & Lillehaug 2014) and yersiniosis caused by Yersinia ruckeri (Bridle & Nowak 2014). During these 25 yr, the major disease problems in farmed fish in Norway have been caused by viruses (i.e.…”

Section: Overall Situation: Bacterial Diseases In Farmed Fishmentioning

confidence: 99%

A pharmaco-epidemiological study of antibacterial treatments and bacterial diseases in Norwegian aquaculture from 2011 to 2016

Lillehaug

Børnes²,

Grave³

2018

Dis. Aquat. Org.

View full text Add to dashboard Cite

The sales and prescription of antibacterials for use in Norwegian fish-farming according to diagnosis, fish species and production stage from 2011 to 2016 are analysed. The study is based on antibacterial sales data from wholesalers, pharmacies and feed mills and on prescription data obtained from a register of all prescriptions of antibacterials used in farmed fish. The results show that the fish-farming industry uses very small volumes of antibacterials. In 2016, a total of 212 kg were sold; the only antibacterial substances sold were florfenicol and oxolinic acid. The total amount corresponded to 0.16 mg kg-1 fish slaughtered, or to approximately 0.14% of the fish produced that year. The majority of prescriptions were for non-specific bacterial infections; as most common diseases are under control by vaccination. Most prescriptions for salmonid fish were during early production stages. However, due to higher biomasses of fish, the highest quantities of antibacterials were prescribed during the seawater production phase of Atlantic salmon Salmo salar. An increasing proportion of the prescriptions was for other species, including cleaner fish used for salmon lice control; in 2016 most prescriptions were for this fish category. Due to the negligible use of antibacterials in Norwegian aquaculture, in particular for on-growers, the risk of development of antimicrobial resistance and its transmission to humans through consumption of fish is considered negligible.

show abstract

Vaccination against Yersiniosis

Cited by 2 publications

References 43 publications

A review on the recent advances and application of vaccines against fish pathogens in aquaculture

A review on the recent advances and application of vaccines against fish pathogens in aquaculture

A pharmaco-epidemiological study of antibacterial treatments and bacterial diseases in Norwegian aquaculture from 2011 to 2016

Contact Info

Product

Resources

About